The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
AFT-50 EndoMAP: A phase IB/II multi-cohort study of targeted agents for patients with recurrent or persistent endometrial cancer.
 
Evelyn Cantillo
No Relationships to Disclose
 
Tyler J. Zemla
No Relationships to Disclose
 
John William Moroney
No Relationships to Disclose
 
Edwin A Alvarez
Consulting or Advisory Role - Eisai; GlaxoSmithKline; Immunogen; OncoSec
Research Funding - Aravive (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Genentech (Inst); Immunogen (Inst); Merck (Inst); Sumitomo Pharma Oncology (Inst); Tesaro/GSK (Inst); VBL Therapeutics (Inst)
 
Lauren Yauch
Employment - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
 
Yvonne Gail Lin
Employment - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
Consulting or Advisory Role - Venn Biosciences Corporation
 
JaneMichelle Michelle Brockman
Employment - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
Patents, Royalties, Other Intellectual Property - Employed by Genentech, a member of the Roche group.
Travel, Accommodations, Expenses - Genentech/Roche
 
Gillian DiLallo
Employment - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
Travel, Accommodations, Expenses - Genentech/Roche
 
Joyce F. Liu
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Clovis Oncology; Eisai; Genentech/Roche; GlaxoSmithKline; Regeneron
Research Funding - 2X Oncology (Inst); Acetylon Pharmaceuticals (Inst); Agenus (Inst); Aravive (Inst); Arch Oncology (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); CytomX Therapeutics (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); IMPAC Medical Systems (Inst); Regeneron (Inst); Vigeo Therapeutics (Inst); Zentalis (Inst)
 
Angeles Alvarez Secord
Honoraria - Myriad Genetics
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Clovis Oncology (Inst); Eisai (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Immutep (Inst); Merck (Inst); OncoQuest Pharmaceuticals (Inst); PharmaMar (Inst); Seagen (Inst); Tesaro (Inst); VBL Therapeutics (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline
(OPTIONAL) Uncompensated Relationships - Aravive; GOG Foundation; OncoQuest Pharmaceuticals; Regeneron; Roche/Genentech; VBL Therapeutics
 
Andrew B. Nixon
Consulting or Advisory Role - AdjuVolt; Leap Therapeutics; Promega
Research Funding - AstraZeneca/MedImmune (Inst); Genentech/Roche (Inst); Genmab (Inst); HTG Molecular Diagnostics (Inst); medpacto (Inst); Promega (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - Patent (Inst); Patent Pending (Inst)
 
Sumithra J. Mandrekar
Honoraria - BeiGene
Consulting or Advisory Role - Flatiron Health; Harbinger Oncology, Inc
Other Relationship - Beigene
 
Ursula A. Matulonis
Honoraria - Advaxis; Alkermes; Symphogen
Consulting or Advisory Role - 2X Oncology; Agenus; AstraZeneca; Blueprint Medicines; Boehringer Ingelheim; GlaxoSmithKline; Immunogen; Merck; NextCure; Novartis; Trillium Therapeutics
Research Funding - Fujifilm; Immunogen; Leap Therapeutics; Merck; Mersana; Novartis; SQZ Biotech; Syndax; Tesaro
Travel, Accommodations, Expenses - AstraZeneca
 
David E. Kozono
Honoraria - Reflexion Medical
Consulting or Advisory Role - Genentech
 
Brian M. Slomovitz
Consulting or Advisory Role - Agenus; AstraZeneca; Eisai; EQRx; Genentech; GlaxoSmithKline; GOG Foundation; Incyte; Lilly; Merck; Myriad Genetics; Nuvation Bio; Onconova Therapeutics; Onconova Therapeutics; Regeneron